These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Practical experiences with the anti-D-IgG prevention of Rh-immunization]. Bergmann H, Leinzinger E, Pazdernik I, Haider M. Wien Med Wochenschr; 1969 Jan 04; 119(1):9-12. PubMed ID: 4975236 [No Abstract] [Full Text] [Related]
43. [The Kleihauer test and directed prevention of hemolytic disease of the newborn due to materno-fetal Rh-factor isoimmunization. Preventive note]. De Luca P, Adinolfi G, Corbo M. Minerva Ginecol; 1980 Dec 04; 32(12):1179-81. PubMed ID: 6793940 [No Abstract] [Full Text] [Related]
44. [3 cases of anti-c(hr') isoimmunization-induced hemolytic disease of the newborn]. Lange MM, Lumare A. Minerva Pediatr; 1972 Feb 11; 24(4):148-52. PubMed ID: 4622335 [No Abstract] [Full Text] [Related]
45. Amniocentesis and intrauterine transfusion in Rh-sensitized pregnancy. Little B, McCutcheon E, Desforges JF. N Engl J Med; 1966 Feb 10; 274(6):332-5. PubMed ID: 4955259 [No Abstract] [Full Text] [Related]
46. [Serology and prophylaxis of Rhesus-caused hemolytic disease of the newborn]. Maresch W. Wien Med Wochenschr; 1966 Nov 11; 116(46):972-4. PubMed ID: 4966249 [No Abstract] [Full Text] [Related]
47. Current management of hemolytic disease of the newborn infant. Naiman JL. J Pediatr; 1972 Jun 11; 80(6):1049-59. PubMed ID: 4112666 [No Abstract] [Full Text] [Related]
49. Ten-year experience with high titer anti-D plasma for the prevention of Rh isoimmunization. Hamilton EG. Obstet Gynecol; 1972 Nov 11; 40(5):692-6. PubMed ID: 4628388 [No Abstract] [Full Text] [Related]
50. [Problems of ABO hemolytic disease in the newborn infant]. Novachev D, Markov L. Akush Ginekol (Sofiia); 1980 Nov 11; 19(3):253-7. PubMed ID: 6992621 [No Abstract] [Full Text] [Related]
51. [Hemolytic disease of the newborn from the viewpoint of the pediatrician]. Janovský M, Polácek K. Cesk Gynekol; 1969 Oct 11; 34(8):485-8. PubMed ID: 4982153 [No Abstract] [Full Text] [Related]
52. [Haemolytic disease of the newborn (fetus) (author's transl)]. Fischer K, Poschmann A. Immun Infekt; 1976 Dec 11; 4(6):249-60. PubMed ID: 828142 [Abstract] [Full Text] [Related]
53. [Hemolytic disease of newborn caused by anti-c antibody]. Tóth A, Vágvölgyi E, Trézli I. Orv Hetil; 1982 Aug 08; 123(32):1983-4. PubMed ID: 6815609 [No Abstract] [Full Text] [Related]
54. [Observations concerning the prevention of rhesus immunization in the Netherlands]. de Bruijne JI, van der Weerdt CM, Stallman HF, Hartgerink MJ, borst-Eilers E, Dudok de Wit C. Ned Tijdschr Geneeskd; 1968 Dec 28; 112(52):2367-70. PubMed ID: 4974071 [No Abstract] [Full Text] [Related]
55. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. VII. Indications for exchange transfusion in Rh-incompatibility]. Schneeweiss B. Padiatr Grenzgeb; 1970 Dec 28; 9(3):208-17. PubMed ID: 4997628 [No Abstract] [Full Text] [Related]
56. [Aspects of ABO blood group incompatibility in the pre- and postnatal periods]. Novachev D, Markov L. Akush Ginekol (Sofiia); 1980 Dec 28; 19(4):322-8. PubMed ID: 6774626 [No Abstract] [Full Text] [Related]
57. The prevention of Rh-haemolytic disease. Clarke CA. Sci Basis Med Annu Rev; 1968 Dec 28; ():168-85. PubMed ID: 4970016 [No Abstract] [Full Text] [Related]
58. Rhesus disease: the model for fetal therapy. Nicolaides KH, Rodeck CH. Br J Hosp Med; 1985 Sep 28; 34(3):141-8. PubMed ID: 3933599 [Abstract] [Full Text] [Related]
59. [Hemolytic disease of the newborn and therapeutic anti-allergic antibodies]. Guimbretière J, Dehorne M, Guimbretière L. Rev Fr Transfus; 1969 Sep 28; 12(1):Suppl:395+. PubMed ID: 4987784 [No Abstract] [Full Text] [Related]
60. [Preliminary experiences with the prevention of Rh sensitization]. Aeppli H, Nwebube G. Gynaecologia; 1969 Sep 28; 168(6):481-3. PubMed ID: 4993890 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]